1. Beer HF, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al.In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.J Nucl Med 31:1007–1014, 1990.
2. Innis R, Zoghbi S, Johnson E, Woods S, Al-Tikiriti M, Baldwin R, et al. SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154.Eur J Pharmacol 193: 249–252, 1991.
3. Innis RB, Al-Tikiriti MS, Zoghbi S, Baldwin RM, Sybirska EH, Laruelle MA, et al. SPECT imaging of the benzodiazepine receptor: feasibility ofin vivo potency measurements from stepwise displacement curve.J Nucl Med 32: 1754–1761, 1991.
4. Feistel H, Kaschka WP, Ebert D, Koraschky P, Wolf F. Assessment of cerebral benzodiazepine receptor distribution in anxiety disorders—A study with I-123-IOMAZENIL.J Nucl Med 34: 47, 1993. (abstract)
5. Uchiyama M, Sue H, Fukumitu N, Mori Y, Kawakami K. Assessment cerebral benzodiazepine receptor distribution in anxiety disorder by123I-iomazenil-SPECT: comparison to cerebral perfusion scintigraphy byI23I-IMP.Nippon Acta Radiol 57: 41–46, 1997. (in Japanese)